Resources from the same session
1036O - Relatlimab (RELA) + nivolumab (NIVO) vs. NIVO in previously untreated metastatic or unresectable melanoma: Additional efficacy in RELATIVITY-047
Presenter: F. Stephen Hodi
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
1040O - Phase II trial of ipilimumab, nivolumab and tocilizumab for unresectable metastatic melanoma
Presenter: Jeffrey Weber
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
1037O - MASTERKEY-265: A phase III, randomized, placebo (Pbo)-controlled study of talimogene laherparepvec (T) plus pembrolizumab (P) for unresectable stage IIIB–IVM1c melanoma (MEL)
Presenter: Helen Gogas
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Q&A and live discussion
Presenter: Olivier Michielin
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Slides
Webcast
Invited Discussant 1037O
Presenter: James Larkin
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: James Larkin
Session: Proffered Paper session - Melanoma and other skin tumours
Resources:
Slides
Webcast